Recent publications on neuromuscular disorders

Recent publications on neuromuscular disorders

Neurorntac. Disord., Vol. 2. No. I, pp. 71-72, 1992 Printed in Great Britain RECENT PUBLICATIONS 0960-8966/92$5.00 + 0.00 Pergamon Press Ltd ON NEU...

156KB Sizes 20 Downloads 29 Views

Neurorntac. Disord., Vol. 2. No. I, pp. 71-72, 1992 Printed in Great Britain

RECENT PUBLICATIONS

0960-8966/92$5.00 + 0.00 Pergamon Press Ltd

ON NEUROMUSCULAR

DISORDERS*

Cohen-Kaminsky S, Jacques Y, Aime C, Safar D, Morel E, Berrih-Aknin S. Follow-up of soluble interleukin-2 receptor levels after thymectomy in patients with myasthenia gravis. Clin Immunol Immunopathol 1992; 62: 190-198. Cullen M J, Fulthorpe J J, Harris J B. The distribution of desmin and titin in normal and dystrophic human muscle. Acta Neuropathol 1992; 83: 158-169. Ehara S, Nakasato T, Tamakawa Y, Yamataka H, Murakami H, Abe M. MRI of myositis ossificans circumscripta. Clin Imaging 1991; 15: 130-134. Florence J M, Pandya S, King W M, et al. Intrarater reliability of manual muscle test (Medical Research Council scale) grades in Duchenne's muscular dystrophy. Phys Ther 1992; 72:115-126. Gemignani F, Guidetti D, Bizzi P, Preda P, Cenacchi G, Marbini A. Peroneal muscular atrophy with hereditary spastic paraparesis (HMSN V) is pathologically heterogeneous: report of nerve biopsy in four cases and review of the literature. Acta Neuropathol 1992; 83: 196-201. Gershoni-Baruch R, Ludatscher R M, Lichtig C, Sujov P, Machoul I. Cerebro-oculo-facioskeletal syndrome: further delineation. Am J Med Genet 1991; 41: 74-77. Hammans S R, Sweeney M G, Holt I J, et al. Evidence for intramitochondrial complementation between deleted and normal mitochondrial DNA in some patients with mitochondrial myopathy. J Neurol Sci 1991; 107: 87-92. Hassel B, Gilhus N E, Aarli J A, Skogen O R. Fulminant myasthenia gravis and polymyositis after thymectomy for thymoma. Acta Neurol Scand 1992; 85: 63-65. Hayashi R, Maruyama T, Maruyama K, Yanagawa S, Tako K, Yanagisawa N. Myotonic and repetitive discharges in hypokalemic myopathy associated with glycyrrhizininduced hypochloremia. JNeurol Sci 1991; 107: 74-77.

Ashizawa T, Hejtmancik J F, Liu J, Perryman M B, Epstein H F, Koch D D. Diagnostic value of ophthalmologic findings in myotonic dystrophy: comparison with risks calculated by haplotype analysis of closely linked restriction fragment length polymorphisms. A m J Med Genet 1992; 42: 55-60. Bach J R, McKeon J. Orthopaedic surgery and rehabilitation for the prolongation of bracefree ambulation of patients with Duchenne muscular dystrophy. Am J Phys Med Rehabil 1991; 70: 323-331. Bately R, Johnson E W. Asthma amyotrophy. Three cases. Am J Phys Med Rehabil 1991; 70: 332-334. Beggs A H, Newmann P E, Arahata K, et al. Possible influences in the expression of X chromosome-linked dystrophin abnormalities by heterozygosity for autosomal recessive Fukuyama congenital muscular dystrophy. Proc Natl Acad Sci USA 1992; 89: 623-627. Ben Hamida M, Milardi N, Turki I, Zaiem H. Duchenne muscular dystrophy in Tunisia: a clinical and morphological study of 77 cases. J Neurol Sci 1991; 107: 60-64. Brussock C M, Haley S M, Munsat T L, Bernhardt D B. Measurement of isometric force in children with and without Duchenne's muscular dystrophy. Phys Ther 1992; 72:105-114. Chitayat D, Hodgkinson K A, Blaichman S, et al. Syndrome of mental retardation and distal arthrogryposis in sibs. Am J Med Genet 1991; 41: 49-51.

*This SDI printout contains information derived from the Excerpta Medica database Embase, and is prepared for Pergamon Press. N o responsibility is assumed by Elsevier Science Publishers/Excerpta Medica Publishing G r o u p for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, we recommend that independent verification of diagnoses and drug dosages should be made. E S P / E M P G makes no representation or warranty expressed or implied, including but not limited to any implied warranty or merchantability of fitness for a particular purpose, with respect to this SDI printout and specifically disclaims all such warranties and representations. 71

72

Recent Publications

Hernandez R J, Keim D R, Chenevert T L, Sullivan D B, Aisen A M. Fat-suppressed MR imaging of myositis. Radiology 1992; 182:217 219. Heytens L, Martin J J, Van De Kelft E, Bossaert L L. In vitro contracture tests in patients with various neuromuscular diseases. Br J Anaesth 1992; 68: 72-75. Ichikawa Y, Shimizu H, Yoshida M, Arimori S. Two-color flow cytometric analysis of thymic lymphocytes from patients with myasthenia gravis and/or thymoma. Clin Immunol Immunopathol 1992; 62:91-96. Inui K, Fukushima H, Tsukamoto H, et al. Mitochondrial encephalomyopathies with the mutation of the mitochondrial tRNA(Leu) (UUR) gene. JPediatr 1992; 120:62 66. Kosko J R, Brandom B W, Chan K H. Masseter spasm and malignant hyperthermia: a retrospective review of a hospital-based pediatric otolaryngology practice. Int J Pediatr Otorhinolaryngol 1992; 23: 45-50. Linder N, Mathot l, Livoff A, et al. Congenital myopathy with oculo-facial abnormalities (Marden Walker syndrome). Am J Med Genet 1991; 39: 377-379. Miller F, Koreska J. Height measurement of patients with neuromuscular disease and contractures. Dev MedChildNeuro11992; 34: 55-60. Mostacciuolo M L, Micaglio G, Fardin P, Danieli G A. Genetic epidemiology of hereditary motor sensory neuropathies (type I). Am J Med Genet 1991 ; 39:479-481. Ramesh V, Gardner-Medwin D. Familial paroxysmal rhabdomyolysis: management of two cases of non-exertional type. Dev Med Child Neurol 1992; 34: 73-79. Rapaport D, Passos-Bueno M R, Brandao L, Love D, Vainzof M, Zatz M. Apparent association of mental retardation and specific patterns of deletions screened with probes

cf56a and cf23a in Duchenne Muscular Dystrophy. Am J Med Genet 1991 ; 39:437-441. Rietschel M, Rudnik-Schoneborn S, Zerres K. Clinical variability of autosomat dominant spinal muscular atrophy. J Neurol Sci 1991; 107: 65-73. Sigurgeirsson B, Lindelof B, Edhag O, Allander E. Risk of cancer in patients with dermatomyositis or polymyositis-- a population-based study. N Engl J Med 1992; 326: 363-367. Van Essen A J, Abbs S, Baiget M, et al. Parental origin and germline mosaicism of deletions and duplications of the dystrophin gene: a European study. Hum Genet 1992; 88: 249-257. Van Essen A J, Busch H F M, Te Meerman G J, Ten Kate L P. Birth and population prevalence of Duchenne muscular dystrophy in The Netherlands. Hum Genet 1992; 88: 258-266. Volt T, Neuen-Jacob E, Mahler V, Jauch A, Cremer M. Somatic mosaicism for a deletion of the dystrophin gene in a carrier of Becker muscular dystrophy. Eur J Pediatr 1992; 151: 112 116. Wieder D L. Treatment of traumatic myositis ossificans with acetic acid iontophoresis. Phys Ther 1992; 72: 133-137. Wijburg F A, Rosenblatt D S, Vos G D, et al. Clinical and biochemical observations in a patient with combined Pompe disease and cblC mutation. Eur J Pediatr 1992; 151:127--131. Williams L L, Kissel J T, Shannon B T, Wright F S, Mandeli J R. Expression of Schwann cell and peripheral T-cell activation epitopes in hereditary motor and sensory neuropathy. J Neuroimmunol 1992; 36:147 155. Yip T-C K, Houle S, Tittley J G, Walker P M. Quantification of skeletal muscle necrosis in the lower extremities using sup 9sup 9Tcsup m pyrophosphate with single photon emission computed tomography. Nucl Med Commun 1992; 13: 47-52.